EXACT Therapeutics AS (EXTX) Stock Overview

EXACT Therapeutics AS, a clinical stage biopharmaceutical company, develops a technology platform for targeted therapeutic enhancement, Acoustic Cluster Therapy (ACT). The ACT is an approach to ultrasound-mediated, targeted drug enhancement with the potential to amplify the clinical utility of a range of therapeutic agents across various indications, including within oncology, infectious diseases, and brain diseases. The company's ACT platform is under Phase I multi-center international clinical trial in patients with liver metastases secondary to colorectal/pancreatic cancer. EXACT Therapeutics AS has a collaboration with GE Healthcare to support the research of immunotherapy responses in solid tumors with ACT. The company was formerly known as Phoenix Solutions AS. EXACT Therapeutics AS was incorporated in 2012 and is based in Oslo, Norway.